These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 9670361)
21. RUTI: a new chance to shorten the treatment of latent tuberculosis infection. Cardona PJ Tuberculosis (Edinb); 2006; 86(3-4):273-89. PubMed ID: 16545981 [TBL] [Abstract][Full Text] [Related]
22. A novel benzothiazinethione analogue SKLB-TB1001 displays potent antimycobacterial activities in a series of murine models. Gao C; Ye TH; Peng CT; Shi YJ; You XY; Xiong L; Ran K; Zhang LD; Zeng XX; Wang NY; Yu LT; Wei YQ Biomed Pharmacother; 2017 Apr; 88():603-609. PubMed ID: 28142116 [TBL] [Abstract][Full Text] [Related]
23. [A guinea pig model of latent Mycobacterium tuberculosis H₃₇Rv infection]. Li YL; Chen BW; Xu M; Luo YA; Wang GZ; Shen XB; Su C Zhonghua Jie He He Hu Xi Za Zhi; 2010 Sep; 33(9):684-7. PubMed ID: 21092637 [TBL] [Abstract][Full Text] [Related]
24. Mycobacterium tuberculosis persistence in various adipose depots of infected mice and the effect of anti-tubercular therapy. Agarwal P; Khan SR; Verma SC; Beg M; Singh K; Mitra K; Gaikwad AN; Akhtar MS; Krishnan MY Microbes Infect; 2014 Jul; 16(7):571-80. PubMed ID: 24819214 [TBL] [Abstract][Full Text] [Related]
25. Usefulness of acr expression for monitoring latent Mycobacterium tuberculosis bacilli in 'in vitro' and 'in vivo' experimental models. Gordillo S; Guirado E; Gil O; Díaz J; Amat I; Molinos S; Vilaplana C; Ausina V; Cardona PJ Scand J Immunol; 2006 Jul; 64(1):30-9. PubMed ID: 16784488 [TBL] [Abstract][Full Text] [Related]
26. A review of murine models of latent tuberculosis infection. Shi C; Shi J; Xu Z Scand J Infect Dis; 2011 Dec; 43(11-12):848-56. PubMed ID: 21892898 [TBL] [Abstract][Full Text] [Related]
27. Durable cure for tuberculosis: rifalazil in combination with isoniazid in a murine model of Mycobacterium tuberculosis infection. Shoen CM; DeStefano MS; Cynamon MH Clin Infect Dis; 2000 Jun; 30 Suppl 3():S288-90. PubMed ID: 10875802 [TBL] [Abstract][Full Text] [Related]
28. Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosis. Lanoix JP; Lenaerts AJ; Nuermberger EL Dis Model Mech; 2015 Jun; 8(6):603-10. PubMed ID: 26035868 [TBL] [Abstract][Full Text] [Related]
29. [Action of dissolved ozone on mycobacterium tuberculosis and alveolar macrophages in experimental tuberculosis]. Belianin II; Nikolaeva GM; Martynova LP Probl Tuberk; 1997; (1):56-9. PubMed ID: 9162932 [TBL] [Abstract][Full Text] [Related]
30. Unique model of dormant infection for tuberculosis vaccine development. Kashino SS; Ovendale P; Izzo A; Campos-Neto A Clin Vaccine Immunol; 2006 Sep; 13(9):1014-21. PubMed ID: 16960113 [TBL] [Abstract][Full Text] [Related]
31. Specific bacterial genotypes of Mycobacterium tuberculosis cause extensive dissemination and brain infection in an experimental model. Hernandez Pando R; Aguilar D; Cohen I; Guerrero M; Ribon W; Acosta P; Orozco H; Marquina B; Salinas C; Rembao D; Espitia C Tuberculosis (Edinb); 2010 Jul; 90(4):268-77. PubMed ID: 20580613 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of moxifloxacin & econazole against multidrug resistant (MDR) Mycobacterium tuberculosis in murine model. Gupta UD; Vemuri N; Gupta P; Kumar V; Tanushree P; Khuller GK Indian J Med Res; 2015 Sep; 142(3):323-9. PubMed ID: 26458349 [TBL] [Abstract][Full Text] [Related]
33. Fighting tuberculosis by drugs targeting nonreplicating Iacobino A; Piccaro G; Giannoni F; Mustazzolu A; Fattorini L Int J Mycobacteriol; 2017; 6(3):213-221. PubMed ID: 28776518 [TBL] [Abstract][Full Text] [Related]
34. Distribution of mycobacteria grown in vivo in the organs of intravenously infected mice. Collins FM; Montalbine V Am Rev Respir Dis; 1976 Mar; 113(3):281-6. PubMed ID: 816236 [TBL] [Abstract][Full Text] [Related]
35. Identification of viable and non-viable Mycobacterium tuberculosis in mouse organs by directed RT-PCR for antigen 85B mRNA. Pai SR; Actor JK; Sepulveda E; Hunter RL; Jagannath C Microb Pathog; 2000 Jun; 28(6):335-42. PubMed ID: 10839970 [TBL] [Abstract][Full Text] [Related]
36. Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2. Scanga CA; Mohan VP; Yu K; Joseph H; Tanaka K; Chan J; Flynn JL J Exp Med; 2000 Aug; 192(3):347-58. PubMed ID: 10934223 [TBL] [Abstract][Full Text] [Related]
37. Presence of multiple lesion types with vastly different microenvironments in C3HeB/FeJ mice following aerosol infection with Mycobacterium tuberculosis. Irwin SM; Driver E; Lyon E; Schrupp C; Ryan G; Gonzalez-Juarrero M; Basaraba RJ; Nuermberger EL; Lenaerts AJ Dis Model Mech; 2015 Jun; 8(6):591-602. PubMed ID: 26035867 [TBL] [Abstract][Full Text] [Related]
38. [Therapeutic effects and mechanisms of CpG oligodeoxynucleotides in mice infected with Mycobacterium tuberculosis]. Ren T; Li CY; Cai YY; Jin ML; Hu YW; Yuan ZH; Tian M; Zhao B Zhonghua Jie He He Hu Xi Za Zhi; 2006 Feb; 29(2):87-91. PubMed ID: 16677448 [TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis. Lu J; Yue J; Wu J; Luo R; Hu Z; Li J; Bai Y; Tang Z; Xian Q; Zhang X; Wang H Pharmacology; 2010; 85(6):365-71. PubMed ID: 20530976 [TBL] [Abstract][Full Text] [Related]